Skip to main content

Market Overview

18 Stocks Moving In Friday's Pre-Market Session

Share:

Gainers

  • Stemline Therapeutics Inc (NASDAQ: STML) rose 16.7 percent to $13.25 in pre-market trading after the company reported a FDA deal on expedited pathway to full approval of SL-401 in first-line BPDCN.
  • Gap Inc (NYSE: GPS) rose 8.7 percent to $25.26 in pre-market trading. Gap reported a 2 percent year-over-year gain in its comparable sales for the November and December 2016 holiday season. Gap comparable sales for December rose 4 percent, compared to a 5 percent decline last year.
  • The Medicines Company (NASDAQ: MDCO) rose 8.4 percent to $38.50 in pre-market trading after gaining 0.62 percent on Thursday.
  • Ionis Pharmaceuticals Inc (NASDAQ: IONS) shares rose 8.4 percent to $51.02 in pre-market trading after the company reported a licensing deal with Novartis AG (ADR) (NYSE: NVS).
  • Neurocrine Biosciences, Inc. (NASDAQ: NBIX) shares rose 6.3 percent to $44.00 in pre-market trading. Neurocrine issued an update on FDA Advisory Committee for INGREZZA for the treatment of tardive dyskinesia.
  • Ability Inc (NASDAQ: ABIL) shares rose 6 percent to $3.40 in pre-market trading after climbing 3.88 percent on Thursday.
  • Helen of Troy Limited (NASDAQ: HELE) shares rose 5.3 percent to $94.00 in pre-market trading. Helen of Troy reported better-than-expected earnings for its third quarter, but sales missed expectations. The company raised its earnings forecast for the year, but lowered its sales outlook.
  • CTI BioPharma Corp (NASDAQ: CTIC) rose 5 percent to $4.68 in pre-market trading after surging 12.34 percent on Thursday.
  • Zafgen Inc (NASDAQ: ZFGN) rose 4.5 percent to $3.50 in pre-market trading after gaining 0.60 percent on Thursday.
  • Amgen, Inc. (NASDAQ: AMGN) rose 4.3 percent to $159.50 in pre-market trading after the company disclosed that it has won a court ruling for a ban on Sanofi's sales of praluent cholestrol drug.
  • Nutanix Inc (NASDAQ: NTNX) shares rose 4.2 percent to $27.87 in pre-market trading after declining 4.91 percent on Thursday.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Losers

  • Ruby Tuesday, Inc. (NYSE: RT) shares fell 12.8 percent to $3.08 in pre-market trading after the company posted a wider quarterly loss. Ruby Tuesday reported Q2 adjusted loss of $0.18 per share on revenue of $214.7 million.
  • G-III Apparel Group, Ltd. (NASDAQ: GIII) shares fell 9.2 percent to $26.02 in pre-market trading after the company lowered its guidance for FY17.
  • Regeneron Pharmaceuticals Inc (NASDAQ: REGN) fell 4.7 percent to $362.98 in pre-market trading. Amgen won a court ruling for a ban on Regeneron’s sales of Praluent cholestrol drug.
  • Arconic Inc (NYSE: ARNC) shares fell around 5.3 percent to $19.03 in pre-market trading after gaining 2.03 percent on Thursday.
  • Pandora Media Inc (NYSE: P) fell 4 percent to $12.50 in pre-market trading.
  • Orexigen Therapeutics, Inc. (NASDAQ: OREX) fell 4.5 percent to $3.61 in pre-market trading after climbing 11.18 percent on Thursday.
  • GoPro Inc (NASDAQ: GPRO) shares fell around 3 percent to $9.07 in pre-market trading. Longbow Research downgraded GoPro from Neutral to Underperform.
 

Related Articles (GPS + STML)

View Comments and Join the Discussion!

Posted-In: #PreMarket Gainers LosersNews Movers & Shakers Pre-Market Outlook Markets Movers

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com